Updated Tuesday, October 24, 2017
 Journal Tools
RSS Feed
Sample Copy
Submit a Manuscript
Contact Us
Subscription
Advertising
Thanking Peer Reviewers
 Language Polishing
Journal of Integrative Medicine: Volume 15, 2017   Issue 5,  Pages: 407–410

DOI: 10.1016/S2095-4964(17)60366-2
Case Report
Leech therapy in treatment of cutaneous leishmaniasis: a case report
1. Nasrin Hamidizadeh (Molecular Dermatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran )
2. Amir Azizi (Research Center for Traditional Medicine and History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran )
3. Mohammad M. Zarshenas (Departments of Phytopharmaceuticals (Traditional) Pharmacy, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran )
4. Sara Ranjbar (Molecular Dermatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran )
Welcome to JIM! You are the number 270 reader of this article!
Download Article:
[Full Text]      [PDF]      [Previous]      [This Issue]
Please cite this article as:
Hamidizadeh N, Azizi A, Zarshenas MM, Ranjbar S. Leech therapy in treatment of cutaneous leishmaniasis: a case report. J Integr Med. 2017; 15(5): 407–410.
References:
1Adams SL. The medicinal leech: a page from the annelids of internal medicine[J].Ann Intern Med, 1988, 109(5): 399–405.  
2Fields WS. The history of leeching and hirudin[J].Haemostasis, 1991, 21(Suppl 1): 3–10.  
3Porshinsky BS, Saha S, Grossman MD, Beery II PR, Stawicki SP. Clinical uses of the medicinal leech: a practical review[J].J Postgrad Med, 2001, 57(1): 65–71.  
4Glyova O. The beter letter: modern hirudotherapy—-a review[J].Biother Educ Res Found, 2005, 2(1): 1, 3.  
5Fort CW. Leech therapy: current uses for an old treatment[J].DNA Reporter, 2001, 26: 16–17.  
6Barzegar A, Azizi A, Faridi P, Mohagheghzadeh A. Leech therapy in Iranian traditional medicine[J].Forsch Komplementmed, 2015, 22(1): 50–53.  
7World Health Organization. Report of the consultative meeting on cutaneous leishmaniasis. Geneva: World Health Organization Press. 2007.
8Razmjou S, Hejazy H, Motazedian MH, Baghaei M, Emamy M, Kalantary M. A new focus of zoonotic cutaneous leishmaniasis in Shiraz, Iran[J].Trans R Soc Trop Med Hyg, 2009, 103(7): 727–730.  
9Oshaghi MA, Rasolian M, Shirzadi MR, Mohtarami F, Doosti S. First report on isolation of Leishmania tropica from sandflies of a classical urban cutaneous leishmaniasis focus in Southern Iran[J].Exp Parasitol, 2010, 126(4): 445–450.  
10Masmoudi A, Hariz W, Marrekchi S, Amouri M, Turki H. Old World cutaneous leishmaniasis: diagnosis and treatment[J].J Dermatol Case Rep, 2013, 7(2): 31–41.  
11Reithinger R, Dujardin JC, Louzir H, Pirmez C, Alexander B, Brooker S. Cutaneous leishmaniasis[J].Lancet Infect Dis, 2007, 7(9): 581–596.  
12Utevsky SY, Trontelj P. A new species of the medicinal leech (Oligochaeta, Hirudinida, Hirudo) from Transcaucasia and an identification key for the genus Hirudo[J].Parasitol Res, 2005, 98(1): 61–66.  
13Nadim A. Current situation with regard to leishmaniasis in the countries of the eastern Mediterranean Region—an overview. In: Walton BC, MF Wijeyaratne PM. Research on control strategies for leishmaniasis[M]. Ottawa: IDRC, 1988. 162–167.  
14Asgari Q, Motazedian MH, Mehrabani D, Oryan A, Hatam GR, Owji SM, Paykari H. Zoonotic cutaneous leishmaniasis in Shiraz, Southern Iran: a molecular, isoenzyme and morphologic approach[J].J Res Med Sci, 2007, 12(1): 7–15.  
15Murray HW, Berman JD, Davies CR, Saravia NG. Advances in leishmaniasis[J].Lancet, 2005, 366(9496): 1561–1577.  
16Desjeux P. Leishmaniasis: current situation and new perspectives[J].Comp Immunol Microbiol Infect Dis, 2004, 27(5): 305–318.  
17Franke ED, Wignall FS, Cruz ME, Rosales E, Tovar AA, Lucas CM, Llanos-Cuentas A, Berman JD. Efficacy and toxicity of sodium stibogluconate for mucosal leishmaniasis[J].Ann Intern Med, 1990, 113(12): 934–940.  
18Berman JD. Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years[J].Clin Infect Dis, 1997, 24(4): 684–703.  
19Croft S, Sundar S, Fairlamb AH. Drug resistance in leishmaniasis[J].Clin Microbiol Rev, 2006, 19(1): 111–126.  
20Ahmad T, Mohd A. Clinical importance of leech therapy[J].Indian J Tradit Knowl, 2009, 8(3): 443–445.  
21Eldor A, Orevi M, Rigbi M. The role of the leech in medical therapeutics[J].Blood Rev, 1996, 10(4): 201–209.  
22Chang JY. The functional domain of hirudin, a thrombin-specific inhibitor[J].FEBS Lett, 1983, 164(2): 307–313.  
23Bichler J, Fritz H. Hirudin, a new therapeutic tool? Ann Hematol. 1991; 63(2): 67–76.
24Seemüller U, Dodt J, Fink E, Fritz H. Proteinase inhibitors of the leech Hirudo medicinalis (hirudins, bdellins, eglins). In: Barrett AJ, Salves G. Proteinase inhibitors[M]. New York: Elsevier Science Ltd, 1986. 337–359.  
25Zavalova LL, Baskova IP, Lukyanov SA, Sass AV, Snezhkov EV, Akopov SB, Artamonova II, Archipova VS, Nesmeyanov VA, Kozlov DG, Benevolensky SV, Kiseleva VI, Poverenny AM, Sverdlov ED. Destabilase from the medicinal leech is a representative of a novel family of lysozymes[J].Biochim Biophys Acta, 2000, 1478(1): 69–77.  
26Sawyer RT. Leech biology and behavior: volume II: feeding biology, ecology, and systematics. Oxford: Oxford Science Publications. 1986.
27Godfrey K. Uses of leeches and leech saliva in clinical practice[J].Nurs Times, 1997, 93(9): 62–63.  
28Rigbi M, Levy H, Eldor A, Iraqi F, Teitelbaum M, Orevi M, Horovitz A, Galun R. The saliva of the medicinal leech Hirudo medicinalis—II. inhibition of platelet aggregation and of leukocyte activity and examination of reputed anaesthetic effects[J].Comp Biochem Physiol C, 1987, 88(1): 95–98.  
29Kumar SA, Prakash SO. Analgesic and anti-inflammatory activity of leech therapy in the management of arthritis[J].Intern Res J Pharm, 2011, 2(12): 172–174.  
30S?llner C, Mentele R, Eckerskorn C, Fritz H, Sommerhoff CP. Isolation and characterization of hirustasin, an antistasin-type serine-proteinase inhibitor from the medical leech Hirudo medicinalis[J].Eur J Biochem, 1994, 219(3): 937–943.  
31Reverter D, Vendrell J, Canals F, Horstmann J, Avilés FX, Fritz H, Sommerhoff CP. A carboxypeptidase inhibitor from the medical leech Hirudo medicinalis. Isolation, sequence analysis, cDNA cloning, recombinant expression, and characterization[J].J Biol Chem, 1998, 273(49): 32927–32933.  
32Reverter D, Fernández-Catalán C, Baumgartner R, Pf?nder R, Huber R, Bode W, Vendrell J, Holak TA, Avilés FX. Structure of a novel leech carboxypeptidase inhibitor determined free in solution and in complex with human carboxypeptidase A2[J].Nat Struct Biol, 2000, 7(4): 322–328.  
33Michalsen A, Roth M, Dobos GJ. Medicinal leech therapy. New York: Thieme Medical Publishers. 2007.
34Zaidi SM, Jameel SS, Zaman F, Jilani S, Sultana A, Khan SA. A systematic overview of the medicinal importance of sanguivorous leeches[J].Altern Med Rev, 2011, 16(1): 59–65.  
35Abdualkader AM, Ghawi AM, Alaama M, Awang M, Merzouk A. Leech therapeutic applications[J].Indian J Pharm Sci, 2013, 75(2): 127–137.  
 Home | Current Issue | Past Issues | SearchRSS
Copyright © 2013-2018 by JIM Editorial Office. All rights reserved. ISSN 2095-4964; CN 31-2083/R. 沪ICP备110264号